Therefore, in this scenario, TIMP1-induced activation of the PI3K/Akt pathway and subsequent upregulation of GPX4 contribute to resistance against sorafenib-triggered ferroptosis in colorectal cancer cells (Wang L. et al., 2023). Here, GPX4 is linked to colorectal cancer.